Byrna (BYRN) director sells 5,000 shares at $29 via 10b5-1
Byrna Technologies (BYRN) reported an insider transaction on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Byrna Technologies (BYRN) reported an insider transaction on a Form 4. A company Director and Chairman of the Board sold 5,000 shares of common stock on 10/10/2025 at $29.00 per share.
The sale was made under a Rule 10b5-1 trading plan adopted on April 16, 2025. Following the transaction, the reporting person beneficially owns 130,226 shares, held directly.
Insights
Routine 10b5-1 insider sale; neutral impact
The filing shows a pre-planned sale of 5,000 BYRN shares at $29.00 on 10/10/2025 under a Rule 10b5-1 plan adopted on April 16, 2025. Such plans automate trades to reduce discretion.
Post-transaction holdings are 130,226 shares, reported as direct ownership. This appears administrative and does not alter the company’s operations or capital structure. Actual market impact depends on broader trading volumes and holder activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $29.00 | $145K |
Footnotes (1)
- F1. The shares were sold pursuant to a 10b5-1 plan adopted April 16, 2025 in multiple transactions, each at $29.00. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding each transaction.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Byrna Technologies (BYRN) disclose in this Form 4?
Was the BYRN insider sale pre-planned?
What is the reporting person’s role at Byrna Technologies (BYRN)?
AI-generated analysis. How Rhea-AI works. Not financial advice.